PMID: 9431334Feb 7, 1998Paper

Gender and psychotropic drug use

Medical Care
L Simoni-Wastila

Abstract

Although studies have documented women's greater use of prescribed psychotropic drugs, few have explicitly examined how women and men differ in psychotropic drug use. This study examines gender differences in aggregate psychotropic drug use, as well as use of specific therapeutic categories, and explores how other factors explaining psychotropic drug use vary by gender. Using 1989 National Ambulatory Medical Care Survey (NAMCS) data, logistic regression analysis is used to estimate the probability of psychotropic drug use in aggregate and for four therapeutic categories--anxiolytics, sedative-hypnotics, antidepressants, and antipsychotics. For equations where gender is statistically significant, separate logistic regression equations are estimated to determine the explanatory variables that vary by gender. The probability of receiving any psychotropic drug is 55% greater in office visits by women than those by men, all else constant. Further, gender is a positive and significant predictor of anxiolytic and antidepressant use. Variables estimating anxiolytic and antidepressant use that differ by gender include diagnosis, physician specialty, and payment source for the office visit. Findings confirm research that has demonstrated...Continue Reading

References

Jun 1, 1978·Journal of Health and Social Behavior·P J Bush, M Osterweis
May 1, 1991·American Journal of Public Health·M SwartzK Smith
Apr 1, 1990·Medical Care·G L Cafferata, S M Meyers
Dec 1, 1988·Archives of General Psychiatry·R S BeardsleyJ Hidalgo
Sep 1, 1985·Journal of Health and Social Behavior·L M Verbrugge
Jan 20, 1984·JAMA : the Journal of the American Medical Association·G D MellingerE H Uhlenhuth
Oct 1, 1984·Archives of General Psychiatry·L N RobinsD A Regier
Jun 1, 1983·Journal of Health and Social Behavior·G L CafferataA Bernstein
Jan 1, 1982·Social Science & Medicine·R Cooperstock, P Parnell
Jun 13, 1994·Archives of Internal Medicine·M Olfson, H A Pincus
Jul 27, 1994·JAMA : the Journal of the American Medical Association·S M WillcoxS Woolhandler
Aug 7, 1993·BMJ : British Medical Journal·F W van der WaalsM Foets
Sep 1, 1993·The Annals of Pharmacotherapy·T M JörgensenM Thorslund
Sep 1, 1993·Medical Care·A DelgadoJ D Luna

❮ Previous
Next ❯

Citations

Sep 26, 2002·Pharmacoepidemiology and Drug Safety·L K Montane JaimeF Ramsewak
Jul 26, 2002·Pharmacoepidemiology and Drug Safety·Catherine M RoeBrenda R Motheral
Nov 7, 2012·Journal of General Internal Medicine·Danya M Qato, Amal N Trivedi
Feb 1, 2002·Social Science & Medicine·Anne E RhodesJ Ivan Williams
Feb 26, 2003·Social Science & Medicine·Betsy Sleath, Ya-Chen Tina Shih
Feb 5, 2013·CNS Spectrums·Donatella MarazzitiLiliana Dell'Osso
Mar 22, 2002·Nursing & Health Sciences·J M LantzG R Sadler
Apr 29, 2000·Journal of Women's Health & Gender-based Medicine·L Simoni-Wastila
Sep 26, 2001·Journal of Women's Health & Gender-based Medicine·K D BertakisJ A Robbins
Nov 20, 2002·Clinical Obstetrics and Gynecology·Carol C Nadelson, Leah Dickstein
Feb 24, 2006·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Linda Simoni-WastilaVan Doren Hsu
Feb 5, 2004·American Journal of Public Health·Linda Simoni-Wastila, Gail Strickler
Jul 26, 2006·The American Journal of Drug and Alcohol Abuse·Andrea R VansickelCraig R Rush
Oct 27, 2012·Journal of the American Medical Directors Association·Philipe de Souto BarretoYves Rolland
Feb 23, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Joy SimpsonJohn P Kelly
Mar 6, 2010·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·M Sami Walid, Nadezhda V Zaytseva
Aug 28, 2007·The American Journal of Geriatric Pharmacotherapy·Arlene S BiermanDan R Berlowitz
Feb 14, 2007·The American Journal of Geriatric Pharmacotherapy·Linda Simoni-Wastila, Huiwen Keri Yang
Oct 16, 2004·Journal of Clinical Pharmacy and Therapeutics·M BaumannF Alla
Jan 28, 2005·Journal of the American Geriatrics Society·Robyn TamblynGillian Bartlett
Nov 4, 2006·Pharmacoepidemiology and Drug Safety·P Carrasco-GarridoA Gil de Miguel
Feb 28, 2003·Journal of Clinical Pharmacy and Therapeutics·F EmpereurS Briançon
Jun 9, 2015·European Psychiatry : the Journal of the Association of European Psychiatrists·A BoydUNKNOWN EU-WMH investigators
Dec 23, 2014·Journal of Affective Disorders·Alina KarantiMikael Landén
Mar 7, 2013·Substance Use & Misuse·Shannon L StewartWendy den Dunnen
Oct 21, 2003·The Annals of Pharmacotherapy·Kelli L DominickDebra A Heller
Mar 11, 2003·Substance Use & Misuse·Li-Tzy Wu, William E Schlenger
Jan 6, 2005·AIDS Patient Care and STDs·Michelle D FurlerReina Bendayan
Mar 9, 2004·Substance Use & Misuse·Linda Simoni-WastilaGail Strickler
Apr 17, 2001·The Annals of Pharmacotherapy·B L SleathS A Huston
Dec 7, 2020·The Journal of Antimicrobial Chemotherapy·Françoise LivioUNKNOWN Swiss HIV Cohort Study
Feb 21, 2021·European Journal of Hospital Pharmacy. Science and Practice·María Isabel Santos-PérezLuis H Martín-Arias

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here